Aperio Group, LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2020$91,000
-69.4%
18,924
-62.9%
0.00%
-100.0%
Q3 2020$297,000
+133.9%
51,011
+171.8%
0.00%
Q2 2020$127,000
+15.5%
18,770
+8.8%
0.00%
Q1 2020$110,000
+129.2%
17,249
+433.2%
0.00%
Q2 2019$48,000
-82.0%
3,235
-36.1%
0.00%
-100.0%
Q1 2018$267,000
-22.6%
5,060
-0.3%
0.00%
-50.0%
Q4 2017$345,000
-20.5%
5,073
-3.6%
0.00%0.0%
Q3 2017$434,000
-9.0%
5,261
+3.3%
0.00%
-33.3%
Q2 2017$477,000
+49.5%
5,093
+1.7%
0.00%
+50.0%
Q1 2017$319,000
+10.8%
5,010
+60.2%
0.00%
-33.3%
Q3 2015$288,000
+14.7%
3,127
+9.7%
0.00%0.0%
Q2 2015$251,000
+16.2%
2,851
-2.1%
0.00%
+50.0%
Q1 2015$216,0002,9120.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2015
NameSharesValueWeighting ↓
Versant Venture Management, LLC 407,416$14,259,560,0008.34%
Palo Alto Investors LP 3,547,719$124,170,0006.91%
Antipodean Advisors LLC 1,268,658$44,403,0006.48%
Redmile Group, LLC 1,795,936$62,858,0004.70%
HealthCor Management, L.P. 1,525,000$53,375,0003.24%
PointState Capital LP 3,503,900$122,637,0003.12%
NEA Management Company, LLC 1,139,890$39,896,0002.54%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 612,500$21,438,0002.44%
PFM Health Sciences, LP 2,078,440$72,745,0002.21%
Partner Investment Management, L.P. 35,300$1,236,0002.03%
View complete list of CLOVIS ONCOLOGY INC shareholders